Clinical Outcomes and Prognostic Factors Associated With Acanthamoeba Keratitis : Cornea

Secondary Logo

Journal Logo

Clinical Science

Clinical Outcomes and Prognostic Factors Associated With Acanthamoeba Keratitis

Chew, Hall F MD, FRCS(C); Yildiz, Elvin H MD; Hammersmith, Kristin M MD; Eagle, Ralph C Jr MD; Rapuano, Christopher J MD; Laibson, Peter R MD; Ayres, Brandon D MD; Jin, Ya-Ping MD, PhD; Cohen, Elisabeth J MD

Author Information
Cornea 30(4):p 435-441, April 2011. | DOI: 10.1097/ICO.0b013e3181ec905f



To describe the clinical characteristics, time of presentation, risk factors, treatment, outcomes, and prognostic factors on a recent series of Acanthamoeba keratitis (AK) treated at our institution.


Retrospective case series of 59 patients diagnosed with AK from January 1, 2004 to December 31, 2008. Of these 59 patients, 51 had complete follow-up data and were analyzed using univariate and multivariate logistic regression analyses performed with “failure” defined as requiring a penetrating keratoplasty (PKP) and/or having (1) best-corrected visual acuity (BCVA) <20/100 or (2) BCVA <20/25 at the last follow-up. A single multivariate model incorporating age, sex, steroid use before diagnosis, time to diagnosis, initial visual acuity (VA), stromal involvement, and diagnostic method was performed.


Symptom onset was greatest in the summer and lowest in the winter. With failure defined as requiring PKP and/or final BCVA <20/100, univariate analysis suggests that age >50 years, female sex, initial VA <20/50, stromal involvement, and patients with a confirmed tissue diagnosis had a significant risk for failure; however, none of these variables were significant using multivariate analysis. Univariate analysis, with failure defined as requiring PKP and/or final BCVA <20/25, showed stromal involvement and initial VA <20/50 were significant for failure-only initial VA <20/50 was significant using multivariate analysis.


Symptom onset for AK is greatest in the summer. Patients with confirmed tissue diagnosis and female patients may have a higher risk for failure, but a larger prospective population-based study is required to confirm this. Failure is likely associated with patients who present with stromal involvement and patients presenting with an initial BCVA worse than 20/50.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid